Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 33.15% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 64.00M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 64.00M.
Overvalued
The company’s latest PE is 37.27, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 4.83M shares, decreasing 12.87% quarter-over-quarter.
Held by ETHSX
Star Investor ETHSX holds 631.99 shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.10.